Compass Therapeutics grants new employee stock options for 200,000 shares
CMPX•Compass Therapeutics granted a new employee non-qualified stock options to purchase 200,000 common shares under its 2025 Inducement Plan. The options have a $0.86-per-share exercise price, a 10-year term and vest over four years.
1. Option grant details
Compass Therapeutics granted a new employee non-qualified stock options to purchase 200,000 common shares under its 2025 Inducement Plan. The options have a $0.86-per-share exercise price and a 10-year term. They vest 25% on the grant’s first anniversary, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter, subject to continued service.
